oral glp 1 pfizer to discontinue danuglipron, its GLP-1 pill for obesity| STAT Oral GLP-1 Orforglipron Is Approved

Studies exclusively evaluating supraphysiologic androgen dosing, anabolic steroid misuse, or performance enhancement in eugonadal athletes were excluded

Pfizer's decision to halt development of the drug came after "a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators," according to a release

Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial

Triglycerides were significantly reduced at all doses of tirzepatide compared to placebo

GLP-1 receptor agonists (GLP-1RAs) have the potential to reduce these risk factors, but their role in lymphedema has never been investigated